Some veterinarians warn that the tariffs are impacting animal health

Tariffs may be an international issue, but some warn that their impact is putting animal health in jeopardy.

The concern centers around production, with most vaccines and antibiotics made overseas. One large animal veterinarian says costs on critical imported products could go up, forcing tough decisions on the ground.

“A lot of the products, vaccines for example, aren’t necessarily manufactured here in the U.S., so they might come from China, come from India, Brazil. Well, if we’re putting tariffs on products coming into the U.S., what does that do to those products? More expensive, right? And so then, if you’re in a situation where margins are pretty small, what do you do? Maybe you cut preventative care, and so vaccines might be a place that you delay a vaccine program, or maybe you cut it all altogether, and so thinking about this animal health investment,” said Dustin Pendell with the World Organization for Animal Health.

Animal health costs are a small part of a rancher’s budget, but skipping preventative care can put herds at risk. Animal health officials admit that while tariffs might lead to short-term price hikes, it could encourage more vaccine manufacturing here in the United States.

Related Stories
NMPF’s Alan Bjerga discusses pending trade agreements with Indonesia and Ecuador and how they will benefit U.S. dairy producers and improve overall global competitiveness of U.S. ag products.
Debt pressures could reshape farm policy and credit.
India trade tensions may affect the U.S. export outlook.
Tariff revenues rarely flow directly back to farmers.
Weak crop margins and tariff uncertainty are delaying machinery purchases and signaling slower capital investment across U.S. agriculture.
Jeramy Stephens with National Land Realty explains how the Supreme Court’s tariff ruling and ongoing ‘America First’ trade policy raise new questions about U.S. farmland values and agricultural market stability.

LATEST STORIES BY THIS AUTHOR:

Rising adoption of GLP-1 drugs may gradually reshape food demand, with potential downstream effects on protein markets and consumer purchasing patterns.
Traders are keeping a close eye on China’s soybean purchases as markets track export sales, shipments, and progress toward the ‘magical’ 12 million ton target promised last year.
Leadership development and bipartisan engagement remain central to advancing agriculture’s priorities in 2026.
AFBF Economist Faith Parum provides analysis and perspective on the Farmer Bridge Assistance Program—what commodity growers should know and potential remedies for producers facing crop losses where that aid falls short.
In a post to social media, Trump said Venezuela will buy American agriculture products and will use the money from oil sales to make it happen.
Federal nutrition policy is signaling a stronger demand for whole foods produced by U.S. farmers and ranchers. Consumer-facing guidance favors animal protein, but institutional demand may change little under existing saturated fat limits.